Blending Treatments Worldwide for Multiple Myeloma

David S. Siegel, MD, PhD

Video Categories: Hematological Malignancies

David S. Siegel, MD, PhD, at the John Theurer Cancer Center in Hackensack, NJ, explains the benefits of worldwide clinical trials in creating more consistent, less toxic treatment options for multiple myeloma. New drugs are coming along, and the clinical trials for those drugs are beginning to mature.
July 17, 2018

HR+/HER2- Metastatic Breast Cancer: Common Presenting Symptoms

Hope Rugo, MD, discusses common presenting symptoms of HR+/HER2- metastatic breast cancer, citing bone metastasis as the most prevalent.

October 16, 2015

Targeting Multiple Pathways with Immunotherapies

Dr. Sanjiv Agarwala brings up the potential issue of toxicity that may arise in combining immunotherapies and argues that the benefits outweigh the risks.